BIOL logo

BIOLASE (BIOL) Operating Profit

Annual Operating Profit

-$17.94 M
+$7.40 M+29.21%

December 31, 2023


Summary


Performance

BIOL Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherBIOLprofitabilitymetrics:

Quarterly Operating Profit

-$695.00 K
+$2.52 M+78.42%

September 30, 2024


Summary


Performance

BIOL Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherBIOLprofitabilitymetrics:

TTM Operating Profit

-$13.52 M
+$3.00 M+18.17%

September 30, 2024


Summary


Performance

BIOL TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherBIOLprofitabilitymetrics:

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

BIOL Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+29.2%+81.2%+36.5%
3 y3 years+3.2%+81.2%+36.5%
5 y5 years+1.4%+81.2%+36.5%

BIOL Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+11.3%+41.3%at high+1112.5%at high+95.5%
5 y5-year+14.8%+41.3%at high+1112.5%at high+95.5%
alltimeall time-359.0%+41.3%-127.3%+1268.2%-289.4%+95.5%

BIOLASE Operating Profit History

DateAnnualQuarterlyTTM
Sep 2024
-
-$695.00 K(-78.4%)
-$13.52 M(-18.2%)
Jun 2024
-
-$3.22 M(-28.9%)
-$16.52 M(-3.8%)
Mar 2024
-
-$4.53 M(-10.8%)
-$17.17 M(-4.3%)
Dec 2023
-$17.94 M(-29.2%)
-$5.08 M(+37.3%)
-$17.94 M(-15.7%)
Sep 2023
-
-$3.70 M(-4.5%)
-$21.29 M(-15.7%)
Jun 2023
-
-$3.87 M(-26.8%)
-$25.24 M(-4.5%)
Mar 2023
-
-$5.29 M(-37.2%)
-$26.42 M(+4.3%)
Dec 2022
-$25.34 M(+57.2%)
-$8.43 M(+10.1%)
-$25.34 M(+19.4%)
Sep 2022
-
-$7.65 M(+51.4%)
-$21.22 M(+31.0%)
Jun 2022
-
-$5.05 M(+20.2%)
-$16.19 M(+12.9%)
Mar 2022
-
-$4.21 M(-2.3%)
-$14.35 M(-11.0%)
Dec 2021
-$16.12 M(-13.1%)
-$4.30 M(+63.8%)
-$16.12 M(-7.1%)
Sep 2021
-
-$2.63 M(-18.2%)
-$17.35 M(-5.6%)
Jun 2021
-
-$3.21 M(-46.2%)
-$18.39 M(-4.0%)
Mar 2021
-
-$5.97 M(+7.8%)
-$19.16 M(+3.4%)
Dec 2020
-$18.54 M(+18.7%)
-$5.54 M(+51.0%)
-$18.54 M(+15.5%)
Sep 2020
-
-$3.67 M(-7.8%)
-$16.05 M(-7.0%)
Jun 2020
-
-$3.98 M(-25.7%)
-$17.26 M(+2.7%)
Mar 2020
-
-$5.35 M(+75.6%)
-$16.81 M(+7.5%)
Dec 2019
-$15.62 M(-14.2%)
-$3.05 M(-37.6%)
-$15.63 M(-4.7%)
Sep 2019
-
-$4.88 M(+38.4%)
-$16.41 M(+2.3%)
Jun 2019
-
-$3.53 M(-15.5%)
-$16.04 M(-6.7%)
Mar 2019
-
-$4.17 M(+9.1%)
-$17.19 M(-5.5%)
Dec 2018
-$18.20 M(+3.8%)
-$3.83 M(-15.1%)
-$18.20 M(-2.1%)
Sep 2018
-
-$4.51 M(-3.6%)
-$18.59 M(-1.3%)
Jun 2018
-
-$4.68 M(-9.7%)
-$18.84 M(+1.1%)
Mar 2018
-
-$5.18 M(+23.0%)
-$18.64 M(+6.3%)
Dec 2017
-$17.53 M(+17.2%)
-$4.22 M(-11.4%)
-$17.53 M(+0.6%)
Sep 2017
-
-$4.76 M(+6.3%)
-$17.43 M(+10.2%)
Jun 2017
-
-$4.48 M(+9.9%)
-$15.82 M(+7.4%)
Mar 2017
-
-$4.08 M(-0.9%)
-$14.72 M(-1.6%)
Dec 2016
-$14.96 M(-27.5%)
-$4.11 M(+30.7%)
-$14.96 M(+14.0%)
Sep 2016
-
-$3.15 M(-7.1%)
-$13.12 M(-14.4%)
Jun 2016
-
-$3.39 M(-21.5%)
-$15.33 M(-19.2%)
Mar 2016
-
-$4.31 M(+89.6%)
-$18.97 M(-8.1%)
Dec 2015
-$20.65 M(+15.1%)
-$2.27 M(-57.5%)
-$20.65 M(-7.0%)
Sep 2015
-
-$5.35 M(-23.9%)
-$22.19 M(+10.2%)
Jun 2015
-
-$7.03 M(+17.3%)
-$20.13 M(+4.3%)
Mar 2015
-
-$5.99 M(+56.8%)
-$19.30 M(+7.6%)
Dec 2014
-$17.94 M(+63.2%)
-$3.82 M(+15.9%)
-$17.94 M(+11.1%)
Sep 2014
-
-$3.29 M(-46.8%)
-$16.15 M(-3.4%)
Jun 2014
-
-$6.19 M(+33.6%)
-$16.71 M(+30.4%)
Mar 2014
-
-$4.63 M(+128.8%)
-$12.81 M(+16.5%)
Dec 2013
-$11.00 M(+334.5%)
-$2.03 M(-47.5%)
-$11.00 M(+41.4%)
Sep 2013
-
-$3.86 M(+68.5%)
-$7.78 M(+80.7%)
Jun 2013
-
-$2.29 M(-18.6%)
-$4.30 M(+15.5%)
Mar 2013
-
-$2.82 M(-336.3%)
-$3.73 M(+47.2%)
Dec 2012
-$2.53 M(-36.8%)
$1.19 M(-407.2%)
-$2.53 M(-55.3%)
Sep 2012
-
-$388.00 K(-77.3%)
-$5.67 M(-8.8%)
Jun 2012
-
-$1.71 M(+5.6%)
-$6.22 M(+19.1%)
Mar 2012
-
-$1.62 M(-16.5%)
-$5.22 M(+30.4%)
Dec 2011
-$4.00 M(-65.1%)
-$1.94 M(+107.1%)
-$4.00 M(+140.2%)
Sep 2011
-
-$938.00 K(+30.8%)
-$1.67 M(-47.1%)
Jun 2011
-
-$717.00 K(+76.6%)
-$3.15 M(-51.9%)
Mar 2011
-
-$406.00 K(-203.0%)
-$6.56 M(-42.8%)
Dec 2010
-$11.46 M(+287.2%)
$394.00 K(-116.3%)
-$11.46 M(-13.6%)
Sep 2010
-
-$2.42 M(-41.2%)
-$13.26 M(+33.5%)
Jun 2010
-
-$4.12 M(-22.3%)
-$9.94 M(+197.5%)
Mar 2010
-
-$5.31 M(+276.7%)
-$3.34 M(+12.8%)
Dec 2009
-$2.96 M(-63.9%)
-$1.41 M(-255.9%)
-$2.96 M(-48.8%)
Sep 2009
-
$904.00 K(-63.5%)
-$5.78 M(-44.8%)
Jun 2009
-
$2.47 M(-150.2%)
-$10.48 M(-16.6%)
Mar 2009
-
-$4.93 M(+16.6%)
-$12.56 M(+53.3%)
Dec 2008
-$8.20 M
-$4.23 M(+11.4%)
-$8.20 M(+24.5%)
Sep 2008
-
-$3.79 M(-1082.9%)
-$6.58 M(+3.2%)
DateAnnualQuarterlyTTM
Jun 2008
-
$386.00 K(-168.8%)
-$6.38 M(-17.0%)
Mar 2008
-
-$561.00 K(-78.5%)
-$7.69 M(-14.3%)
Dec 2007
-$8.97 M(+85.4%)
-$2.62 M(-27.1%)
-$8.97 M(+66.0%)
Sep 2007
-
-$3.59 M(+288.8%)
-$5.40 M(+83.3%)
Jun 2007
-
-$923.00 K(-49.9%)
-$2.95 M(-34.0%)
Mar 2007
-
-$1.84 M(-293.4%)
-$4.46 M(-7.8%)
Dec 2006
-$4.84 M(-71.5%)
$953.00 K(-184.0%)
-$4.84 M(-28.7%)
Sep 2006
-
-$1.13 M(-53.5%)
-$6.79 M(-37.4%)
Jun 2006
-
-$2.44 M(+9.9%)
-$10.84 M(-27.4%)
Mar 2006
-
-$2.22 M(+122.6%)
-$14.93 M(-12.0%)
Dec 2005
-$16.98 M(+81.4%)
-$997.00 K(-80.8%)
-$16.98 M(-33.4%)
Sep 2005
-
-$5.19 M(-20.6%)
-$25.49 M(+13.6%)
Jun 2005
-
-$6.53 M(+53.2%)
-$22.45 M(+52.6%)
Mar 2005
-
-$4.26 M(-55.1%)
-$14.71 M(+57.2%)
Dec 2004
-$9.36 M(-235.2%)
-$9.51 M(+343.5%)
-$9.36 M(-482.2%)
Sep 2004
-
-$2.14 M(-277.5%)
$2.45 M(-65.7%)
Jun 2004
-
$1.21 M(+11.3%)
$7.14 M(+0.2%)
Mar 2004
-
$1.08 M(-52.8%)
$7.12 M(+2.9%)
Dec 2003
$6.92 M(+390.4%)
$2.30 M(-9.6%)
$6.92 M(+41.3%)
Sep 2003
-
$2.54 M(+112.9%)
$4.90 M(+76.9%)
Jun 2003
-
$1.20 M(+34.9%)
$2.77 M(+29.5%)
Mar 2003
-
$886.00 K(+222.2%)
$2.14 M(+54.3%)
Dec 2002
$1.41 M(-221.9%)
$275.00 K(-33.6%)
$1.39 M(+99.4%)
Sep 2002
-
$414.00 K(-26.6%)
$695.00 K(+91.5%)
Jun 2002
-
$564.00 K(+324.1%)
$363.00 K(-212.6%)
Mar 2002
-
$133.00 K(-132.0%)
-$322.50 K(-72.1%)
Dec 2001
-$1.16 M(-68.1%)
-$416.00 K(-607.3%)
-$1.16 M(-12.8%)
Sep 2001
-
$82.00 K(-167.5%)
-$1.33 M(-48.1%)
Jun 2001
-
-$121.50 K(-82.7%)
-$2.56 M(-22.9%)
Mar 2001
-
-$702.40 K(+19.8%)
-$3.32 M(-8.6%)
Dec 2000
-$3.63 M(-23.5%)
-$586.20 K(-49.0%)
-$3.63 M(-28.8%)
Sep 2000
-
-$1.15 M(+30.0%)
-$5.10 M(+7.6%)
Jun 2000
-
-$883.30 K(-13.1%)
-$4.74 M(-6.1%)
Mar 2000
-
-$1.02 M(-50.5%)
-$5.05 M(+6.7%)
Dec 1999
-$4.75 M(-6.9%)
-$2.05 M(+160.8%)
-$4.73 M(+10.6%)
Sep 1999
-
-$787.20 K(-34.1%)
-$4.28 M(-14.3%)
Jun 1999
-
-$1.19 M(+70.5%)
-$4.99 M(-0.1%)
Mar 1999
-
-$700.00 K(-56.3%)
-$5.00 M(-2.0%)
Dec 1998
-$5.10 M(+75.9%)
-$1.60 M(+6.7%)
-$5.10 M(+18.6%)
Sep 1998
-
-$1.50 M(+25.0%)
-$4.30 M(+30.3%)
Jun 1998
-
-$1.20 M(+50.0%)
-$3.30 M(+10.0%)
Mar 1998
-
-$800.00 K(0.0%)
-$3.00 M(0.0%)
Dec 1997
-$2.90 M(+16.0%)
-$800.00 K(+60.0%)
-$3.00 M(0.0%)
Sep 1997
-
-$500.00 K(-44.4%)
-$3.00 M(-3.2%)
Jun 1997
-
-$900.00 K(+12.5%)
-$3.10 M(+14.8%)
Mar 1997
-
-$800.00 K(0.0%)
-$2.70 M(+8.0%)
Dec 1996
-$2.50 M(+31.6%)
-$800.00 K(+33.3%)
-$2.50 M(+19.0%)
Sep 1996
-
-$600.00 K(+20.0%)
-$2.10 M(+23.5%)
Jun 1996
-
-$500.00 K(-16.7%)
-$1.70 M(+6.3%)
Mar 1996
-
-$600.00 K(+50.0%)
-$1.60 M(-11.1%)
Dec 1995
-$1.90 M(-51.3%)
-$400.00 K(+100.0%)
-$1.80 M(-37.9%)
Sep 1995
-
-$200.00 K(-50.0%)
-$2.90 M(-19.4%)
Jun 1995
-
-$400.00 K(-50.0%)
-$3.60 M(-2.7%)
Mar 1995
-
-$800.00 K(-46.7%)
-$3.70 M(+37.0%)
Dec 1994
-$3.90 M(-48.0%)
-$1.50 M(+66.7%)
-$2.70 M(-27.0%)
Sep 1994
-
-$900.00 K(+80.0%)
-$3.70 M(-15.9%)
Jun 1994
-
-$500.00 K(-350.0%)
-$4.40 M(-24.1%)
Mar 1994
-
$200.00 K(-108.0%)
-$5.80 M(-22.7%)
Dec 1993
-$7.50 M(+36.4%)
-$2.50 M(+56.3%)
-$7.50 M(+1.4%)
Sep 1993
-
-$1.60 M(-15.8%)
-$7.40 M(+8.8%)
Jun 1993
-
-$1.90 M(+26.7%)
-$6.80 M(+11.5%)
Mar 1993
-
-$1.50 M(-37.5%)
-$6.10 M(+90.6%)
Dec 1992
-$5.50 M
-$2.40 M(+140.0%)
-$3.20 M(+300.0%)
Sep 1992
-
-$1.00 M(-16.7%)
-$800.00 K(-500.0%)
Jun 1992
-
-$1.20 M(-185.7%)
$200.00 K(-85.7%)
Mar 1992
-
$1.40 M
$1.40 M

FAQ

  • What is BIOLASE annual operating income?
  • What is the all time high annual operating profit for BIOLASE?
  • What is BIOLASE annual operating profit year-on-year change?
  • What is BIOLASE quarterly operating income?
  • What is the all time high quarterly operating profit for BIOLASE?
  • What is BIOLASE quarterly operating profit year-on-year change?
  • What is BIOLASE TTM operating income?
  • What is the all time high TTM operating profit for BIOLASE?
  • What is BIOLASE TTM operating profit year-on-year change?

What is BIOLASE annual operating income?

The current annual operating profit of BIOL is -$17.94 M

What is the all time high annual operating profit for BIOLASE?

BIOLASE all-time high annual operating income is $6.92 M

What is BIOLASE annual operating profit year-on-year change?

Over the past year, BIOL annual operating income has changed by +$7.40 M (+29.21%)

What is BIOLASE quarterly operating income?

The current quarterly operating profit of BIOL is -$695.00 K

What is the all time high quarterly operating profit for BIOLASE?

BIOLASE all-time high quarterly operating income is $2.54 M

What is BIOLASE quarterly operating profit year-on-year change?

Over the past year, BIOL quarterly operating income has changed by +$3.00 M (+81.20%)

What is BIOLASE TTM operating income?

The current TTM operating profit of BIOL is -$13.52 M

What is the all time high TTM operating profit for BIOLASE?

BIOLASE all-time high TTM operating income is $7.14 M

What is BIOLASE TTM operating profit year-on-year change?

Over the past year, BIOL TTM operating income has changed by +$7.77 M (+36.50%)